Veru Inc. (VERU) Financials
VERU Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 50.6 million | 32.8 million |
2023-06-30 | 75.2 million | 40.8 million |
2023-03-31 | 70.3 million | 53.5 million |
2022-12-31 | 103.8 million | 54.7 million |
VERU Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -9.7 million | 4.7 million |
2023-06-30 | -18.5 million | 4.6 million |
2023-03-31 | -25.7 million | 3.8 million |
2022-12-31 | -34.8 million | 4.8 million |
VERU Net Income
No data available :(
VERU Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 9.6 million | - | 4.7 million |
2023-06-30 | 16.2 million | - | 4.9 million |
2023-03-31 | 23.5 million | - | 4.0 million |
2022-12-31 | 46.9 million | - | 4.9 million |
VERU Shares Outstanding
VERU Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 212874 | 6.6 million | 6.8 million | - |
2023-06-30 | 25674 | 2.9 million | 6.6 million | - |
2023-03-31 | 141587 | 22.9 million | 12.8 million | - |
2022-12-31 | 285565 | 18.7 million | 17.5 million | - |
VERU Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 3.9 million | 2.3 million |
2023-06-30 | 3.3 million | 2.1 million |
2023-03-31 | 6.6 million | 2.5 million |
2022-12-31 | 2.5 million | 1.8 million |
VERU
Price: $1.64
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.70 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.1 million
Ebitda: -7.3 millionMarket Capitalization: 192.5 million
Average Dividend Frequency: 4